RenalytixAI, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, today announced that it has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA), for its lead diagnostic, KidneyIntelX™. This is the first such designation for an AI-enabled diagnostic for kidney disease publicly announced by any company.FDA Breakthrough Devices Program OverviewThe FDA’s Breakthrough Devices Program is a voluntary program for certain
Read More
Kidney Disease
Smartphone Detection of Chronic Kidney Disease Could Save NHS $877M Over 5 Years
Healthy.io, an Israeli-based provider of FDA-cleared smartphone-based urinalysis has announced the results from its early detection of chronic kidney disease (CKD) pilot study with 2,000 NHS patients with diabetes. The pilot found improved test compliance (raising responses to 72% among patients who had previously not responded to testing reminders) and discovered previously undiagnosed cases of CKD (10 percent of those who took the test).Financial Impact of CKD for the NHSWith a staggering
Read More
Cricket Health Raises $24M to Transform Patient-Centric Kidney Care
Cricket Health, a tech-enabled provider of integrated kidney care, today announced it has raised $24 million in Series A funding led by Oak HC/FT. Other participants in the round include additional new investors include Cigna Corporation, LifeForce Capital, iSeed Ventures, Joe Montana’s Liquid 2 Ventures, Rock Health co-founder Halle Tecco, and Virta Health co-founder Sami Inkinen. Returning investors include First Round Capital, Box Group, Nexus Ventures, Seven Peaks Ventures, Aberdare
Read More
HHS Launches KidneyX to Drive Innovation in Kidney Disease Treatment
The U.S. Department of Health and Human Services (HHS) is teaming up with American Society of Nephrology to launch the Kidney Innovation Accelerator (KidneyX), a a public-private partnership to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases. KidneyX will engage a community of researchers, innovators, and investors to enable and accelerate the commercialization of therapies to benefit people with and at risk for kidney diseases through a series of prize
Read More
